Literature DB >> 24300890

Beta-adrenergic antagonist effects on a novel cognitive flexibility task in rodents.

Patrick M Hecht1, Matthew J Will2, Todd R Schachtman3, Lauren M Welby4, David Q Beversdorf5.   

Abstract

Previous work examining animal models of cognitive flexibility have focused on tasks where animals are required to shift between cues in order to reach a food reward from among a limited set of choices. Performance by nonhuman animals on these tasks, including reversal learning, intradimensional set-shifting, and extradimensional set-shifting, are affected by pharmacological action on serotonergic, dopaminergic, and alpha-adrenergic, but not beta-adrenergic receptors. However, beta-adrenergic antagonists, such as propranolol, are widely utilized for conditions such as test anxiety. Propranolol improves performance in humans during cognitive flexibility tasks where there is a broad set of potential solutions. The current investigation utilized a digging task where the rodent must develop a novel solution in order to obtain a reward. Similar to the effects observed in humans, propranolol improved performance on this task, while not affecting performance on set-shifting tasks, as with previous animal studies. This may allow future investigation of the neurobiological mechanism by which propranolol affects context-specific anxiety, and could provide insight into the neurobiology of creativity.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  ASST; Attentional set-shifting; CD; Cognitive flexibility; Creativity; EDS; IDS; Noradrenergic; Problem solving; Propranolol; SD; attentional set-shifting task; compound discrimination; extradimensional set shift; intradimensional set shift; simple discrimination

Mesh:

Substances:

Year:  2013        PMID: 24300890     DOI: 10.1016/j.bbr.2013.11.041

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  6 in total

Review 1.  Prefrontal cortex executive processes affected by stress in health and disease.

Authors:  Milena Girotti; Samantha M Adler; Sarah E Bulin; Elizabeth A Fucich; Denisse Paredes; David A Morilak
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2017-07-06       Impact factor: 5.067

2.  Neuropsychopharmacological regulation of performance on creativity-related tasks.

Authors:  David Q Beversdorf
Journal:  Curr Opin Behav Sci       Date:  2018-09-27

Review 3.  Neurocognitive Disorders in Heart Failure: Novel Pathophysiological Mechanisms Underpinning Memory Loss and Learning Impairment.

Authors:  C Toledo; D C Andrade; H S Díaz; N C Inestrosa; R Del Rio
Journal:  Mol Neurobiol       Date:  2019-06-05       Impact factor: 5.590

Review 4.  The Role of the Noradrenergic System in Autism Spectrum Disorders, Implications for Treatment.

Authors:  David Q Beversdorf
Journal:  Semin Pediatr Neurol       Date:  2020-06-24       Impact factor: 1.636

5.  Locus Ceruleus Norepinephrine Release: A Central Regulator of CNS Spatio-Temporal Activation?

Authors:  Marco Atzori; Roberto Cuevas-Olguin; Eric Esquivel-Rendon; Francisco Garcia-Oscos; Roberto C Salgado-Delgado; Nadia Saderi; Marcela Miranda-Morales; Mario Treviño; Juan C Pineda; Humberto Salgado
Journal:  Front Synaptic Neurosci       Date:  2016-08-26

6.  Social isolation improves the performance of rodents in a novel cognitive flexibility task.

Authors:  Xin-Yuan Fei; Sha Liu; Yan-Hong Sun; Liang Cheng
Journal:  Front Zool       Date:  2019-11-15       Impact factor: 3.172

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.